Table of Content

1 Veterinary Biological Vaccines Market Overview
1.1 Product Overview and Scope of Veterinary Biological Vaccines
1.2 Veterinary Biological Vaccines Segment by Type
1.2.1 Global Veterinary Biological Vaccines Market Value Comparison by Type (2024-2034)
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Others
1.3 Veterinary Biological Vaccines Segment by Application
1.3.1 Global Veterinary Biological Vaccines Market Value by Application: (2024-2034)
1.3.2 Livestock
1.3.3 Swine
1.3.4 Chicken
1.3.5 Others
1.4 Global Veterinary Biological Vaccines Market Size Estimates and Forecasts
1.4.1 Global Veterinary Biological Vaccines Revenue 2018-2029
1.4.2 Global Veterinary Biological Vaccines Sales 2018-2029
1.4.3 Global Veterinary Biological Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Veterinary Biological Vaccines Market Competition by Manufacturers
2.1 Global Veterinary Biological Vaccines Sales Market Share by Manufacturers (2018-2024)
2.2 Global Veterinary Biological Vaccines Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Veterinary Biological Vaccines Average Price by Manufacturers (2018-2024)
2.4 Global Veterinary Biological Vaccines Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Veterinary Biological Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Biological Vaccines, Product Type & Application
2.7 Veterinary Biological Vaccines Market Competitive Situation and Trends
2.7.1 Veterinary Biological Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Veterinary Biological Vaccines Players Market Share by Revenue
2.7.3 Global Veterinary Biological Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Biological Vaccines Retrospective Market Scenario by Region
3.1 Global Veterinary Biological Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Veterinary Biological Vaccines Global Veterinary Biological Vaccines Sales by Region: 2018-2029
3.2.1 Global Veterinary Biological Vaccines Sales by Region: 2018-2024
3.2.2 Global Veterinary Biological Vaccines Sales by Region: 2024-2029
3.3 Global Veterinary Biological Vaccines Global Veterinary Biological Vaccines Revenue by Region: 2018-2029
3.3.1 Global Veterinary Biological Vaccines Revenue by Region: 2018-2024
3.3.2 Global Veterinary Biological Vaccines Revenue by Region: 2024-2029
3.4 North America Veterinary Biological Vaccines Market Facts & Figures by Country
3.4.1 North America Veterinary Biological Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Veterinary Biological Vaccines Sales by Country (2018-2029)
3.4.3 North America Veterinary Biological Vaccines Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Biological Vaccines Market Facts & Figures by Country
3.5.1 Europe Veterinary Biological Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Veterinary Biological Vaccines Sales by Country (2018-2029)
3.5.3 Europe Veterinary Biological Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Biological Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Veterinary Biological Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Veterinary Biological Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Veterinary Biological Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Veterinary Biological Vaccines Market Facts & Figures by Country
3.7.1 Latin America Veterinary Biological Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Veterinary Biological Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Veterinary Biological Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Biological Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Biological Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Veterinary Biological Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Veterinary Biological Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Biological Vaccines Sales by Type (2018-2029)
4.1.1 Global Veterinary Biological Vaccines Sales by Type (2018-2024)
4.1.2 Global Veterinary Biological Vaccines Sales by Type (2024-2029)
4.1.3 Global Veterinary Biological Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Veterinary Biological Vaccines Revenue by Type (2018-2029)
4.2.1 Global Veterinary Biological Vaccines Revenue by Type (2018-2024)
4.2.2 Global Veterinary Biological Vaccines Revenue by Type (2024-2029)
4.2.3 Global Veterinary Biological Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Veterinary Biological Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global Veterinary Biological Vaccines Sales by Application (2018-2029)
5.1.1 Global Veterinary Biological Vaccines Sales by Application (2018-2024)
5.1.2 Global Veterinary Biological Vaccines Sales by Application (2024-2029)
5.1.3 Global Veterinary Biological Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Veterinary Biological Vaccines Revenue by Application (2018-2029)
5.2.1 Global Veterinary Biological Vaccines Revenue by Application (2018-2024)
5.2.2 Global Veterinary Biological Vaccines Revenue by Application (2024-2029)
5.2.3 Global Veterinary Biological Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Veterinary Biological Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Merck Veterinary Biological Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Corporation Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Zoetis Veterinary Biological Vaccines Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Boehringer Ingelheim Veterinary Biological Vaccines Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Corporation Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Ceva Veterinary Biological Vaccines Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 CAHIC
6.5.1 CAHIC Corporation Information
6.5.2 CAHIC Description and Business Overview
6.5.3 CAHIC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.5.4 CAHIC Veterinary Biological Vaccines Product Portfolio
6.5.5 CAHIC Recent Developments/Updates
6.6 HVRI
6.6.1 HVRI Corporation Information
6.6.2 HVRI Description and Business Overview
6.6.3 HVRI Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.6.4 HVRI Veterinary Biological Vaccines Product Portfolio
6.6.5 HVRI Recent Developments/Updates
6.7 Yebio
6.6.1 Yebio Corporation Information
6.6.2 Yebio Description and Business Overview
6.6.3 Yebio Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Yebio Veterinary Biological Vaccines Product Portfolio
6.7.5 Yebio Recent Developments/Updates
6.8 DHN
6.8.1 DHN Corporation Information
6.8.2 DHN Description and Business Overview
6.8.3 DHN Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.8.4 DHN Veterinary Biological Vaccines Product Portfolio
6.8.5 DHN Recent Developments/Updates
6.9 WINSUN
6.9.1 WINSUN Corporation Information
6.9.2 WINSUN Description and Business Overview
6.9.3 WINSUN Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.9.4 WINSUN Veterinary Biological Vaccines Product Portfolio
6.9.5 WINSUN Recent Developments/Updates
6.10 Elanco
6.10.1 Elanco Corporation Information
6.10.2 Elanco Description and Business Overview
6.10.3 Elanco Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Elanco Veterinary Biological Vaccines Product Portfolio
6.10.5 Elanco Recent Developments/Updates
6.11 Virbac
6.11.1 Virbac Corporation Information
6.11.2 Virbac Veterinary Biological Vaccines Description and Business Overview
6.11.3 Virbac Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Virbac Veterinary Biological Vaccines Product Portfolio
6.11.5 Virbac Recent Developments/Updates
6.12 CAVAC
6.12.1 CAVAC Corporation Information
6.12.2 CAVAC Veterinary Biological Vaccines Description and Business Overview
6.12.3 CAVAC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.12.4 CAVAC Veterinary Biological Vaccines Product Portfolio
6.12.5 CAVAC Recent Developments/Updates
6.13 Kyoto Biken Laboratories
6.13.1 Kyoto Biken Laboratories Corporation Information
6.13.2 Kyoto Biken Laboratories Veterinary Biological Vaccines Description and Business Overview
6.13.3 Kyoto Biken Laboratories Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Kyoto Biken Laboratories Veterinary Biological Vaccines Product Portfolio
6.13.5 Kyoto Biken Laboratories Recent Developments/Updates
6.14 FATRO
6.14.1 FATRO Corporation Information
6.14.2 FATRO Veterinary Biological Vaccines Description and Business Overview
6.14.3 FATRO Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.14.4 FATRO Veterinary Biological Vaccines Product Portfolio
6.14.5 FATRO Recent Developments/Updates
6.15 Vaksindo
6.15.1 Vaksindo Corporation Information
6.15.2 Vaksindo Veterinary Biological Vaccines Description and Business Overview
6.15.3 Vaksindo Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Vaksindo Veterinary Biological Vaccines Product Portfolio
6.15.5 Vaksindo Recent Developments/Updates
6.16 Bio-Labs
6.16.1 Bio-Labs Corporation Information
6.16.2 Bio-Labs Veterinary Biological Vaccines Description and Business Overview
6.16.3 Bio-Labs Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Bio-Labs Veterinary Biological Vaccines Product Portfolio
6.16.5 Bio-Labs Recent Developments/Updates
6.17 Avimex Animal Health
6.17.1 Avimex Animal Health Corporation Information
6.17.2 Avimex Animal Health Veterinary Biological Vaccines Description and Business Overview
6.17.3 Avimex Animal Health Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Avimex Animal Health Veterinary Biological Vaccines Product Portfolio
6.17.5 Avimex Animal Health Recent Developments/Updates
6.18 MEVAC
6.18.1 MEVAC Corporation Information
6.18.2 MEVAC Veterinary Biological Vaccines Description and Business Overview
6.18.3 MEVAC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.18.4 MEVAC Veterinary Biological Vaccines Product Portfolio
6.18.5 MEVAC Recent Developments/Updates
6.19 Biovac
6.19.1 Biovac Corporation Information
6.19.2 Biovac Veterinary Biological Vaccines Description and Business Overview
6.19.3 Biovac Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Biovac Veterinary Biological Vaccines Product Portfolio
6.19.5 Biovac Recent Developments/Updates
6.20 Atafen
6.20.1 Atafen Corporation Information
6.20.2 Atafen Veterinary Biological Vaccines Description and Business Overview
6.20.3 Atafen Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Atafen Veterinary Biological Vaccines Product Portfolio
6.20.5 Atafen Recent Developments/Updates
6.21 Dyntec
6.21.1 Dyntec Corporation Information
6.21.2 Dyntec Veterinary Biological Vaccines Description and Business Overview
6.21.3 Dyntec Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Dyntec Veterinary Biological Vaccines Product Portfolio
6.21.5 Dyntec Recent Developments/Updates
6.22 Ringpu Biology
6.22.1 Ringpu Biology Corporation Information
6.22.2 Ringpu Biology Veterinary Biological Vaccines Description and Business Overview
6.22.3 Ringpu Biology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Ringpu Biology Veterinary Biological Vaccines Product Portfolio
6.22.5 Ringpu Biology Recent Developments/Updates
6.23 Jinyu Bio-technology
6.23.1 Jinyu Bio-technology Corporation Information
6.23.2 Jinyu Bio-technology Veterinary Biological Vaccines Description and Business Overview
6.23.3 Jinyu Bio-technology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.23.4 Jinyu Bio-technology Veterinary Biological Vaccines Product Portfolio
6.23.5 Jinyu Bio-technology Recent Developments/Updates
6.24 Jinhe Biotechnology
6.24.1 Jinhe Biotechnology Corporation Information
6.24.2 Jinhe Biotechnology Veterinary Biological Vaccines Description and Business Overview
6.24.3 Jinhe Biotechnology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.24.4 Jinhe Biotechnology Veterinary Biological Vaccines Product Portfolio
6.24.5 Jinhe Biotechnology Recent Developments/Updates
6.25 China Animal Husbandry Industry
6.25.1 China Animal Husbandry Industry Corporation Information
6.25.2 China Animal Husbandry Industry Veterinary Biological Vaccines Description and Business Overview
6.25.3 China Animal Husbandry Industry Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.25.4 China Animal Husbandry Industry Veterinary Biological Vaccines Product Portfolio
6.25.5 China Animal Husbandry Industry Recent Developments/Updates
6.26 Wuhan Keqian Biology
6.26.1 Wuhan Keqian Biology Corporation Information
6.26.2 Wuhan Keqian Biology Veterinary Biological Vaccines Description and Business Overview
6.26.3 Wuhan Keqian Biology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.26.4 Wuhan Keqian Biology Veterinary Biological Vaccines Product Portfolio
6.26.5 Wuhan Keqian Biology Recent Developments/Updates
6.27 Pulike Biological Engineering
6.27.1 Pulike Biological Engineering Corporation Information
6.27.2 Pulike Biological Engineering Veterinary Biological Vaccines Description and Business Overview
6.27.3 Pulike Biological Engineering Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.27.4 Pulike Biological Engineering Veterinary Biological Vaccines Product Portfolio
6.27.5 Pulike Biological Engineering Recent Developments/Updates
6.28 Chengdu Kanghua Biological Products
6.28.1 Chengdu Kanghua Biological Products Corporation Information
6.28.2 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Description and Business Overview
6.28.3 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.28.4 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Portfolio
6.28.5 Chengdu Kanghua Biological Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Biological Vaccines Industry Chain Analysis
7.2 Veterinary Biological Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Biological Vaccines Production Mode & Process
7.4 Veterinary Biological Vaccines Sales and Marketing
7.4.1 Veterinary Biological Vaccines Sales Channels
7.4.2 Veterinary Biological Vaccines Distributors
7.5 Veterinary Biological Vaccines Customers
8 Veterinary Biological Vaccines Market Dynamics
8.1 Veterinary Biological Vaccines Industry Trends
8.2 Veterinary Biological Vaccines Market Drivers
8.3 Veterinary Biological Vaccines Market Challenges
8.4 Veterinary Biological Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Veterinary Biological Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Veterinary Biological Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Veterinary Biological Vaccines Market Competitive Situation by Manufacturers in 2022
Table 4. Global Veterinary Biological Vaccines Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Veterinary Biological Vaccines Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Veterinary Biological Vaccines Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Veterinary Biological Vaccines Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Veterinary Biological Vaccines Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Veterinary Biological Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Veterinary Biological Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Veterinary Biological Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Veterinary Biological Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Veterinary Biological Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Biological Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Veterinary Biological Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Veterinary Biological Vaccines Sales by Region (2018-2024) & (K Units)
Table 18. Global Veterinary Biological Vaccines Sales Market Share by Region (2018-2024)
Table 19. Global Veterinary Biological Vaccines Sales by Region (2024-2029) & (K Units)
Table 20. Global Veterinary Biological Vaccines Sales Market Share by Region (2024-2029)
Table 21. Global Veterinary Biological Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Veterinary Biological Vaccines Revenue Market Share by Region (2018-2024)
Table 23. Global Veterinary Biological Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Veterinary Biological Vaccines Revenue Market Share by Region (2024-2029)
Table 25. North America Veterinary Biological Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Veterinary Biological Vaccines Sales by Country (2018-2024) & (K Units)
Table 27. North America Veterinary Biological Vaccines Sales by Country (2024-2029) & (K Units)
Table 28. North America Veterinary Biological Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Veterinary Biological Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Veterinary Biological Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Veterinary Biological Vaccines Sales by Country (2018-2024) & (K Units)
Table 32. Europe Veterinary Biological Vaccines Sales by Country (2024-2029) & (K Units)
Table 33. Europe Veterinary Biological Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Veterinary Biological Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Veterinary Biological Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Veterinary Biological Vaccines Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Veterinary Biological Vaccines Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Veterinary Biological Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Veterinary Biological Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Veterinary Biological Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Veterinary Biological Vaccines Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Veterinary Biological Vaccines Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Veterinary Biological Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Veterinary Biological Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Veterinary Biological Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Veterinary Biological Vaccines Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Veterinary Biological Vaccines Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Veterinary Biological Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Veterinary Biological Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Veterinary Biological Vaccines Sales (K Units) by Type (2018-2024)
Table 51. Global Veterinary Biological Vaccines Sales (K Units) by Type (2024-2029)
Table 52. Global Veterinary Biological Vaccines Sales Market Share by Type (2018-2024)
Table 53. Global Veterinary Biological Vaccines Sales Market Share by Type (2024-2029)
Table 54. Global Veterinary Biological Vaccines Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Veterinary Biological Vaccines Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Veterinary Biological Vaccines Revenue Market Share by Type (2018-2024)
Table 57. Global Veterinary Biological Vaccines Revenue Market Share by Type (2024-2029)
Table 58. Global Veterinary Biological Vaccines Price (US$/Unit) by Type (2018-2024)
Table 59. Global Veterinary Biological Vaccines Price (US$/Unit) by Type (2024-2029)
Table 60. Global Veterinary Biological Vaccines Sales (K Units) by Application (2018-2024)
Table 61. Global Veterinary Biological Vaccines Sales (K Units) by Application (2024-2029)
Table 62. Global Veterinary Biological Vaccines Sales Market Share by Application (2018-2024)
Table 63. Global Veterinary Biological Vaccines Sales Market Share by Application (2024-2029)
Table 64. Global Veterinary Biological Vaccines Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Veterinary Biological Vaccines Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Veterinary Biological Vaccines Revenue Market Share by Application (2018-2024)
Table 67. Global Veterinary Biological Vaccines Revenue Market Share by Application (2024-2029)
Table 68. Global Veterinary Biological Vaccines Price (US$/Unit) by Application (2018-2024)
Table 69. Global Veterinary Biological Vaccines Price (US$/Unit) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Merck Veterinary Biological Vaccines Product
Table 74. Merck Recent Developments/Updates
Table 75. Zoetis Corporation Information
Table 76. Zoetis Description and Business Overview
Table 77. Zoetis Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Zoetis Veterinary Biological Vaccines Product
Table 79. Zoetis Recent Developments/Updates
Table 80. Boehringer Ingelheim Corporation Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Boehringer Ingelheim Veterinary Biological Vaccines Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Ceva Corporation Information
Table 86. Ceva Description and Business Overview
Table 87. Ceva Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Ceva Veterinary Biological Vaccines Product
Table 89. Ceva Recent Developments/Updates
Table 90. CAHIC Corporation Information
Table 91. CAHIC Description and Business Overview
Table 92. CAHIC Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. CAHIC Veterinary Biological Vaccines Product
Table 94. CAHIC Recent Developments/Updates
Table 95. HVRI Corporation Information
Table 96. HVRI Description and Business Overview
Table 97. HVRI Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. HVRI Veterinary Biological Vaccines Product
Table 99. HVRI Recent Developments/Updates
Table 100. Yebio Corporation Information
Table 101. Yebio Description and Business Overview
Table 102. Yebio Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Yebio Veterinary Biological Vaccines Product
Table 104. Yebio Recent Developments/Updates
Table 105. DHN Corporation Information
Table 106. DHN Description and Business Overview
Table 107. DHN Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. DHN Veterinary Biological Vaccines Product
Table 109. DHN Recent Developments/Updates
Table 110. WINSUN Corporation Information
Table 111. WINSUN Description and Business Overview
Table 112. WINSUN Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. WINSUN Veterinary Biological Vaccines Product
Table 114. WINSUN Recent Developments/Updates
Table 115. Elanco Corporation Information
Table 116. Elanco Description and Business Overview
Table 117. Elanco Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Elanco Veterinary Biological Vaccines Product
Table 119. Elanco Recent Developments/Updates
Table 120. Virbac Corporation Information
Table 121. Virbac Description and Business Overview
Table 122. Virbac Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Virbac Veterinary Biological Vaccines Product
Table 124. Virbac Recent Developments/Updates
Table 125. CAVAC Corporation Information
Table 126. CAVAC Description and Business Overview
Table 127. CAVAC Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. CAVAC Veterinary Biological Vaccines Product
Table 129. CAVAC Recent Developments/Updates
Table 130. Kyoto Biken Laboratories Corporation Information
Table 131. Kyoto Biken Laboratories Description and Business Overview
Table 132. Kyoto Biken Laboratories Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Kyoto Biken Laboratories Veterinary Biological Vaccines Product
Table 134. Kyoto Biken Laboratories Recent Developments/Updates
Table 135. FATRO Corporation Information
Table 136. FATRO Description and Business Overview
Table 137. FATRO Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. FATRO Veterinary Biological Vaccines Product
Table 139. FATRO Recent Developments/Updates
Table 140. Vaksindo Corporation Information
Table 141. Vaksindo Description and Business Overview
Table 142. Vaksindo Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Vaksindo Veterinary Biological Vaccines Product
Table 144. Vaksindo Recent Developments/Updates
Table 145. Bio-Labs Corporation Information
Table 146. Bio-Labs Description and Business Overview
Table 147. Bio-Labs Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Bio-Labs Veterinary Biological Vaccines Product
Table 149. Bio-Labs Recent Developments/Updates
Table 150. Avimex Animal Health Corporation Information
Table 151. Avimex Animal Health Description and Business Overview
Table 152. Avimex Animal Health Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Avimex Animal Health Veterinary Biological Vaccines Product
Table 154. Avimex Animal Health Recent Developments/Updates
Table 155. MEVAC Corporation Information
Table 156. MEVAC Description and Business Overview
Table 157. MEVAC Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. MEVAC Veterinary Biological Vaccines Product
Table 159. MEVAC Recent Developments/Updates
Table 160. Biovac Corporation Information
Table 161. Biovac Description and Business Overview
Table 162. Biovac Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Biovac Veterinary Biological Vaccines Product
Table 164. Biovac Recent Developments/Updates
Table 165. Atafen Corporation Information
Table 166. Atafen Description and Business Overview
Table 167. Atafen Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Atafen Veterinary Biological Vaccines Product
Table 169. Atafen Recent Developments/Updates
Table 170. Dyntec Corporation Information
Table 171. Dyntec Description and Business Overview
Table 172. Dyntec Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. Dyntec Veterinary Biological Vaccines Product
Table 174. Dyntec Recent Developments/Updates
Table 175. Ringpu Biology Corporation Information
Table 176. Ringpu Biology Description and Business Overview
Table 177. Ringpu Biology Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Ringpu Biology Veterinary Biological Vaccines Product
Table 179. Ringpu Biology Recent Developments/Updates
Table 180. Jinyu Bio-technology Corporation Information
Table 181. Jinyu Bio-technology Description and Business Overview
Table 182. Jinyu Bio-technology Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 183. Jinyu Bio-technology Veterinary Biological Vaccines Product
Table 184. Jinyu Bio-technology Recent Developments/Updates
Table 185. Jinhe Biotechnology Corporation Information
Table 186. Jinhe Biotechnology Description and Business Overview
Table 187. Jinhe Biotechnology Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 188. Jinhe Biotechnology Veterinary Biological Vaccines Product
Table 189. Jinhe Biotechnology Recent Developments/Updates
Table 190. China Animal Husbandry Industry Corporation Information
Table 191. China Animal Husbandry Industry Description and Business Overview
Table 192. China Animal Husbandry Industry Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 193. China Animal Husbandry Industry Veterinary Biological Vaccines Product
Table 194. China Animal Husbandry Industry Recent Developments/Updates
Table 195. Wuhan Keqian Biology Corporation Information
Table 196. Wuhan Keqian Biology Description and Business Overview
Table 197. Wuhan Keqian Biology Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 198. Wuhan Keqian Biology Veterinary Biological Vaccines Product
Table 199. Wuhan Keqian Biology Recent Developments/Updates
Table 200. Pulike Biological Engineering Corporation Information
Table 201. Pulike Biological Engineering Description and Business Overview
Table 202. Pulike Biological Engineering Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 203. Pulike Biological Engineering Veterinary Biological Vaccines Product
Table 204. Pulike Biological Engineering Recent Developments/Updates
Table 205. Chengdu Kanghua Biological Products Corporation Information
Table 206. Chengdu Kanghua Biological Products Description and Business Overview
Table 207. Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 208. Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product
Table 209. Chengdu Kanghua Biological Products Recent Developments/Updates
Table 210. Key Raw Materials Lists
Table 211. Raw Materials Key Suppliers Lists
Table 212. Veterinary Biological Vaccines Distributors List
Table 213. Veterinary Biological Vaccines Customers List
Table 214. Veterinary Biological Vaccines Market Trends
Table 215. Veterinary Biological Vaccines Market Drivers
Table 216. Veterinary Biological Vaccines Market Challenges
Table 217. Veterinary Biological Vaccines Market Restraints
Table 218. Research Programs/Design for This Report
Table 219. Key Data Information from Secondary Sources
Table 220. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Veterinary Biological Vaccines
Figure 2. Global Veterinary Biological Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Veterinary Biological Vaccines Market Share by Type in 2022 & 2029
Figure 4. Live Attenuated Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Others Product Picture
Figure 7. Global Veterinary Biological Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Veterinary Biological Vaccines Market Share by Application in 2022 & 2029
Figure 9. Livestock
Figure 10. Swine
Figure 11. Chicken
Figure 12. Others
Figure 13. Global Veterinary Biological Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Veterinary Biological Vaccines Market Size (2018-2029) & (US$ Million)
Figure 15. Global Veterinary Biological Vaccines Sales (2018-2029) & (K Units)
Figure 16. Global Veterinary Biological Vaccines Average Price (US$/Unit) & (2018-2029)
Figure 17. Veterinary Biological Vaccines Report Years Considered
Figure 18. Veterinary Biological Vaccines Sales Share by Manufacturers in 2022
Figure 19. Global Veterinary Biological Vaccines Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Veterinary Biological Vaccines Players: Market Share by Revenue in 2022
Figure 21. Veterinary Biological Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Veterinary Biological Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Veterinary Biological Vaccines Sales Market Share by Country (2018-2029)
Figure 24. North America Veterinary Biological Vaccines Revenue Market Share by Country (2018-2029)
Figure 25. United States Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Veterinary Biological Vaccines Sales Market Share by Country (2018-2029)
Figure 28. Europe Veterinary Biological Vaccines Revenue Market Share by Country (2018-2029)
Figure 29. Germany Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Veterinary Biological Vaccines Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Veterinary Biological Vaccines Revenue Market Share by Region (2018-2029)
Figure 36. China Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Veterinary Biological Vaccines Sales Market Share by Country (2018-2029)
Figure 46. Latin America Veterinary Biological Vaccines Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Veterinary Biological Vaccines Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Veterinary Biological Vaccines Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Veterinary Biological Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Veterinary Biological Vaccines by Type (2018-2029)
Figure 56. Global Revenue Market Share of Veterinary Biological Vaccines by Type (2018-2029)
Figure 57. Global Veterinary Biological Vaccines Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Veterinary Biological Vaccines by Application (2018-2029)
Figure 59. Global Revenue Market Share of Veterinary Biological Vaccines by Application (2018-2029)
Figure 60. Global Veterinary Biological Vaccines Price (US$/Unit) by Application (2018-2029)
Figure 61. Veterinary Biological Vaccines Value Chain
Figure 62. Veterinary Biological Vaccines Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed